OS Therapies
Biotechnology company with a recent SEC Form D offering.
Biotechnology company headquartered in Grasonville, MARYLAND. Filed SEC Form D on 20261023 for a $7.2M Regulation D offering.
Biotech
📍 Grasonville, MARYLAND
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is OS Therapies going public?
No. OS Therapies is private and has not filed to go public. There is no S-1 on file.
What is OS Therapies' valuation in 2026?
No confirmed valuation is on record for OS Therapies. The roster shows funding and investors where they are public; it does not estimate a mark.
Has OS Therapies filed an S-1?
No public S-1 is on file for OS Therapies.
How much has OS Therapies raised?
OS Therapies has raised $7.17M in total, most recently a Form D filing of $7.17M in 20261023.
Is OS Therapies publicly traded — can you buy OS Therapies stock?
No. OS Therapies is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for OS Therapies on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Growth
Filed SEC Form D on 20261023 for $7.2M Regulation D offering
Last Round
Form D filing — $7.17M (20261023)
Fundraising Status
Form D filing · $7.17M
privateTotal raised $7.17M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Form D filing | $7.17M | 20261023 | — | — |
Vertical Intelligence — Biotech / Gene Therapy
Biotech / Gene Therapy registry data for OS Therapies has not been collected yet — the weekly vertical sweep hasn't reached this company. Check back soon.
Talent Signal
Hiring data for OS Therapies has not been collected yet — the monthly talent sweep hasn't reached this company. Check back soon.
BiotechForm DRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.